Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene
US9315826B2 · kind B2 · utility
0Cited by
10References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 31, 2011 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Jan 31, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/12171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention contemplates a new synthetic, codon-optimized Sin Nombre virus (SNV) full-length M gene open reading frame (ORF) that encodes a unique consensus amino acid sequence. The SNV ORF was cloned into a plasmid to form the first stable recombinant SNV full-length M gene that elicits neutralizing antibodies. The gene can be engineered into a vaccine system, and is useful to protect mammals against infection with Sin Nombre virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.